Does Chicory Root Fiber Constipation Meta-Analysis work?

Updated July 2026

Quick Answer

Chicory Root Fiber Constipation Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: NDO supplementation significantly increased stool frequency overall, with larger effects in constipated individuals (SMD 0.99, 95% CI 0.58-1.28) than in non-constipated population (SMD 0.30, 95% CI 0.10-0.51).

Key Takeaways

  • 01NDO supplementation significantly increased stool frequency overall, with larger effects in constipated individuals (SMD 0.99, 95% CI 0.58-1.28) than in non-constipated population (SMD 0.30, 95% CI 0.10-0.51). [Chen H (2025)]
  • 02However, evidence certainty remains low due to heterogeneity and study limitations. [Chen H (2025)]
  • 03Non-digestible oligosaccharides (NDOs) are short-chain carbohydrates that resist digestion and may improve bowel function. [Chen H (2025)]
  • 04This systematic review and meta-analysis examines the effect of NDOs on constipation-related outcomes in humans. [Chen H (2025)]
The current Migaku evidence database contains 2 reusable source documents for Chicory Root Fiber Constipation Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - NDO supplementation significantly increased stool frequency overall, with larger effects in constipated individuals (SMD 0.99, 95% CI 0.58-1.28) than in non-constipated population (SMD 0.30, 95% CI 0.10-0.51). [Chen H (2025); evidence level 1] - However, evidence certainty remains low due to heterogeneity and study limitations. [Chen H (2025); evidence level 1] - Non-digestible oligosaccharides (NDOs) are short-chain carbohydrates that resist digestion and may improve bowel function. [Chen H (2025); evidence level 1] - This systematic review and meta-analysis examines the effect of NDOs on constipation-related outcomes in humans. [Chen H (2025); evidence level 1] - At the taxonomic level, pregnancy is typically associated with an expansion of the phyla Pseudomonadota (formerly Proteobacteria) and Actinomycetota (formerly Actinobacteria), alongside an increase in the relative abundance of specific genera such as(,). [Cai Linyan (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Non-Digestible Oligosaccharides and Constipation: A Systematic Review and Meta-Analysis of Randomized Trials on Stool Frequency, Stool Consistency, and Fermentation Biomarkers.
  2. Gestational constipation and the gut microbiota: mechanisms, interventions, and implications for maternal and offspring health